HomeIMNM • NASDAQ
add
Immunome Inc
Previous close
$9.40
Day range
$8.82 - $9.53
Year range
$8.55 - $30.96
Market cap
558.01M USD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 2.91M | -18.37% |
Operating expense | 9.53M | 117.74% |
Net income | -47.10M | -984.00% |
Net profit margin | -1.62K | -1,227.99% |
Earnings per share | -0.78 | — |
EBITDA | -43.40M | -859.86% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 240.13M | 164.92% |
Total assets | 256.90M | 175.76% |
Total liabilities | 41.99M | -51.78% |
Total equity | 214.91M | — |
Shares outstanding | 62.42M | — |
Price to book | 2.64 | — |
Return on assets | -39.61% | — |
Return on capital | -46.20% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -47.10M | -984.00% |
Cash from operations | -34.17M | -296.64% |
Cash from investing | 24.10M | 67,038.89% |
Cash from financing | 305.00K | -99.50% |
Net change in cash | -9.76M | -118.70% |
Free cash flow | -26.14M | -459.13% |
About
Founded
2006
Headquarters
Website
Employees
105